Walk into almost any large organisation and you will find a portfolio of impressive AI pilots. Walk back in a year and most of them will still be pilots. The hardest, least glamorous and most valuable problem in enterprise AI is not building a model that works in a demo — it is getting it into production, keeping it there, and having people actually use it. The leaders who can do that are a different profile from the ones who can build the demo, and in 2026 they are the ones worth paying for.

Key takeaways

• Most enterprise AI value is lost in the gap between a working pilot and a deployed, monitored, trusted system.
• Operationalising AI is an organisational skill as much as a technical one: integration, monitoring, change management and adoption.
• The leader who builds the most impressive prototype is often not the leader who can ship and sustain it. Hiring for the demo is hiring for the wrong job.
• In regulated domains, production also means defensible: monitored, documented and governed for the long term.
• Screen for a track record of things that reached production and stayed there — not for the cleverest proof of concept.

Why pilots stall

Pilots stall for reasons that have little to do with the model and everything to do with the organisation around it. The data pipeline that worked on a curated sample breaks on live data. No one owns monitoring, so quiet drift goes unnoticed. The workflow it was meant to support never actually changed, so clinicians or analysts route around it. None of these are research problems; they are operational and human ones. This is why the scarce, valuable leader is the one who treats deployment, monitoring and adoption as the real work — not as an afterthought once the clever part is done.

The graveyard of corporate AI is full of dazzling pilots and empty of deployed, monitored, trusted systems. Shipping is the hard part.

The profile that ships

The operationaliser looks different from the researcher. They are as comfortable with change management and stakeholder trust as with architecture. They design for monitoring from day one. They know that in healthcare and life sciences, “in production” also means defensible — documented, overseen and able to satisfy clinical governance and the incoming EU AI Act. It is, in other words, the builder-and-steward profile we described in building a healthcare AI leadership team and returned to in our 2026 hiring outlook: technically credible, but valued for judgement and follow-through rather than novelty.

Why this profile is scarce — and mispriced

The market still tends to pay the largest premiums for the most dazzling builders, which means the operationalisers — the people who quietly get things live and keep them there — are frequently undervalued relative to the impact they have. That is the mispricing we flagged across the talent shortage: the constraint is not people who can build, it is people who can land. For a buyer, that is an opportunity, if you know to screen for it.

How to hire for production, not for the demo

Change what you test for. Instead of admiring the prototype, ask what the candidate has taken into production, what broke, how they monitored it, and what happened to adoption a year later. Probe for the unglamorous work: integration, drift monitoring, retraining, the politics of changing a workflow. This is precisely the kind of judgement a technical screen alone will miss, and precisely what disciplined executive search is built to assess — and it connects directly to the leadership questions in our guide to hiring data leadership.

AI that never leaves the lab changes nothing. The leaders who can take it the last, hardest mile — from pilot to production, and keep it there — are the ones who turn an anxious AI budget into something real. In 2026, that is the hire worth getting right.

Banba is a specialist executive search firm for AI, machine learning and data science leadership, with a focus on healthcare and life sciences, and offices in New York, London and Berlin.